Study on cannabis and chronic pain management

The University of Michigan is enrolling patients in two studies on cannabis and its use in the management of chronic pain to garner insights into how cannabis use affects pain management, quality of life, and the use of other pain-relieving medications.
Seeking input from chronic pain sufferers
By Project CBD On July 09, 2018

The University of Michigan is now conducting TWO studies on medical cannabis and we’d like you to participate!

The information you provide will help inform physicians, researchers, policy-makers, and patients about potential benefits and risks of cannabis as a therapeutic or recreational agent.

Study 1: The purpose of this study is to understand how medical cannabis use among patients with chronic pain affects pain management, quality of life, and the use of other medications. In this study, you will be asked to complete an online anonymous, confidential survey. Anyone over the age of 18 who uses cannabis for chronic pain and has a medical cannabis license OR who uses cannabis medically in a place with legal recreational cannabis can participate by clicking this link. The password is UMsurvey.

Study 2: The purpose of this study is to understand how medical cannabis use among patients with chronic pain affects pain management, quality of life, and the use of other medications. In this study, you will be asked to complete online anonymous, confidential surveys at baseline (within the next week), as well as 3, 6, 9, and 12 months after the initial survey. Study participants will be compensated after completing each survey: $10 after this survey, and $10 after each follow-up survey.

You are eligible to participate in this study if all the conditions below are met:

  1. You are 18 years of age or older.
  2. You have a medical cannabis certification in your state of residence.
  3. You either have been using cannabis for chronic pain main management for less than six months OR you plan to but have not started using cannabis for chronic pain management.

If you think you will not be able to participate at all follow-up points, please do NOT participate in this survey.

If you fulfill all these criteria and are still interested in participating, please contact
Dr. Kevin Boehnke PhD at [email protected]